Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Draft Order amending the Common Package of Benefits of the Spanish National Health System

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

The considered issues include:

  • Clarification of provision criteria of eye readers or other communication systems for patients with severe neuromotor disorders;
  • Specifications for the neonatal screening program for hypoacusia;
  • The update of the neonatal screening program for endocrine, metabolic diseases with the inclusion of biotinidase deficiency, maple syrup urine disease, homocystinuria, and congenital adrenal hyperplasia;
  • The incorporation of the circulating free fetal DNA test as a second-level test for the detection of trisomies 21, 18, and 13 in prenatal screening;
  • Specifications in relation to prenatal screening for infectious diseases;
  • The update of the Common Package of Benefits in the area of genetic testing;
  • Maintenance of the endobronchial valves in patients with persistent air leaks in the Common Package of Benefits under the same conditions as in the monitoring study protocol;
  • The expansion and specification of the portfolio of oral health care services;
  • Inclusion of financing of home enteral nutrition for patients with advanced chronic kidney disease on hemodialysis;
  • Harmonization of the indications for radiopharmaceuticals in PET and PET-CT.

All the included benefits have been agreed with the Autonomous Communities within the Commission of Benefits, Insurance, and Financing and approved in the plenary session of the Interterritorial Council for the SNS, after a process of prior evaluation of the available scientific evidence on the safety, efficacy, and cost-effectiveness carried out by the Spanish Network of Agencies for the Evaluation of Health Technologies and Benefits (RedETS).

It is expected that this Order will improve equity in access to care by expanding, specifying, and clarifying the content of the Common Package of Benefits of the SNS so that the offered services are more homogeneous throughout the national territory.

The full details in Spanish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.